VSIR and systemic sclerosis: PSGL-1 and VISTA deficiency results in enhanced T cell activation and exacerbates autoimmune conditions, such as systemic sclerosis (SSc), systemic lupus erythematosus (SLE), and experimental autoimmune encephalitis (EAE) Fig. 3.